COc1nc(NC2OCC(OC(C)=O)C(OC(C)=O)C2OC(C)=O)c(-c2csc(N)n2)c(=O)n1C
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?